WKWM
LLY icon

Walter & Keenan Wealth Management’s Eli Lilly LLY Stock Holding History

Walter & Keenan Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.7M Sell
21,368
-283
-1% -$287K 5.53% 2
2025
Q4 		$23.3M Sell
21,651
-887
-4% -$848K 6.24% 2
2025
Q3 		$17.2M Buy
22,538
+244
+1% +$182K 4.77% 3
2025
Q2 		$17.4M Sell
22,294
-2,309
-9% -$1.79M 5.05% 3
2025
Q1 		$20.3M Buy
24,603
+15
+0.1% +$12.5K 6.12% 1
2024
Q4 		$19M Sell
24,588
-900
-4% -$745K 5.74% 2
2024
Q3 		$22.6M Sell
25,488
-258
-1% -$232K 6.86% 1
2024
Q2 		$23.3M Sell
25,746
-143
-0.6% -$114K 7.42% 1
2024
Q1 		$20.1M Sell
25,889
-690
-3% -$491K 6.6% 1
2023
Q4 		$15.5M Sell
26,579
-1,024
-4% -$598K 5.54% 2
2023
Q3 		$14.8M Sell
27,603
-650
-2% -$335K 5.78% 2
2023
Q2 		$13.3M Sell
28,253
-985
-3% -$413K 4.87% 3
2023
Q1 		$10M Buy
29,238
+389
+1% +$131K 3.81% 3
2022
Q4 		$10.6M Sell
28,849
-1,010
-3% -$358K 4.15% 2
2022
Q3 		$9.65M Sell
29,859
-223
-0.7% -$70.7K 4.09% 3
2022
Q2 		$9.75M Sell
30,082
-789
-3% -$237K 3.86% 3
2022
Q1 		$8.85M Sell
30,871
-650
-2% -$167K 3% 5
2021
Q4 		$8.71M Sell
31,521
-2,145
-6% -$544K 2.83% 4
2021
Q3 		$7.78M Sell
33,666
-527
-2% -$130K 2.64% 6
2021
Q2 		$7.85M Sell
34,193
-3,949
-10% -$793K 2.71% 6
2021
Q1 		$7.13M Buy
38,142
+113
+0.3% +$22.1K 2.52% 9
2020
Q4 		$6.42M Sell
38,029
-1,267
-3% -$189K 2.32% 11
2020
Q3 		$5.82M Sell
39,296
-599
-2% -$92.7K 2.31% 11
2020
Q2 		$6.55M Sell
39,895
-6,135
-13% -$942K 2.66% 5
2020
Q1 		$6.28M Buy
46,030
+5,222
+13% +$717K 2.49% 10
2019
Q4 		$5.36M Sell
40,808
-2,453
-6% -$284K 2.06% 13
2019
Q3 		$4.84M Buy
43,261
+2,287
+6% +$255K 1.84% 17
2019
Q2 		$4.54M Sell
40,974
-15
-0% -$1.77K 2% 14
2019
Q1 		$5.32M Sell
40,989
-2,034
-5% -$247K 2.34% 13
2018
Q4 		$4.98M Sell
43,023
-550
-1% -$61.4K 2.24% 12
2018
Q3 		$4.68K Sell
43,573
-250
-0.6% -$25K 1.4% 16
2018
Q2 		$3.74M Buy
43,823
+300
+0.7% +$24.6K 1.61% 16
2018
Q1 		$3.37M Buy
43,523
+250
+0.6% +$20.1K 1.46% 19
2017
Q4 		$3.65M Buy
43,273
+2,253
+5% +$192K 1.54% 19
2017
Q3 		$3.51M Sell
41,020
-300
-0.7% -$24.6K 1.62% 17
2017
Q2 		$3.4M Sell
41,320
-5,900
-12% -$481K 1.71% 15
2017
Q1 		$3.97M Sell
47,220
-1,520
-3% -$122K 2.06% 12
2016
Q4 		$3.58M Hold
48,740
– – 1.91% 14
2016
Q3 		$3.91M Hold
48,740
– – 2.16% 11
2016
Q2 		$3.84M Hold
48,740
– – 2.14% 11
2016
Q1 		$3.51M Sell
48,740
-800
-2% -$60.5K 2.01% 12
2015
Q4 		$4.17M Sell
49,540
-485
-1% -$40.2K 2.43% 10
2015
Q3 		$4.19M Hold
50,025
– – 2.59% 8
2015
Q2 		$4.18M Hold
50,025
– – 2.42% 9
2015
Q1 		$3.63M Hold
50,025
– – 2.06% 11
2014
Q4 		$3.45M Hold
50,025
– – 1.96% 11
2014
Q3 		$3.22M Buy
50,025
+115
+0.2% +$7.28K 1.89% 11
2014
Q2 		$3.1M Buy
49,910
+1,025
+2% +$61.2K 1.62% 14
2014
Q1 		$2.88M Buy
+48,885
New +$2.73M 1.58% 15

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Walter & Keenan Wealth Management's LLY Position: Q1 2026 in Review

Walter & Keenan Wealth Management reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $287K and leaving 21,368 shares worth $19.7M. The position accounts for 5.53% of the portfolio, ranked #2.

Walter & Keenan Wealth Management first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. The position peaked at $23.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Walter & Keenan Wealth Management held 21,368 shares of Eli Lilly worth $19.7M as of Q1 2026.
  • Walter & Keenan Wealth Management sold 283 Eli Lilly shares in Q1 2026, an estimated $287K.
  • Eli Lilly made up 5.53% of Walter & Keenan Wealth Management's portfolio in Q1 2026, its #2 holding.
  • Walter & Keenan Wealth Management first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
  • Walter & Keenan Wealth Management's Eli Lilly position peaked at $23.3M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Walter & Keenan Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.